Martin V Hamann
Overview
Explore the profile of Martin V Hamann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamann M, Adiba M, Lange U
BMC Med Genomics
. 2023 Apr;
16(1):68.
PMID: 37013607
Background: Human endogenous retroviruses (HERV) are repetitive sequence elements and a substantial part of the human genome. Their role in development has been well documented and there is now mounting...
2.
Hamann M, Beschorner N, Vu X, Hauber I, Lange U, Traenkle B, et al.
PLoS One
. 2021 Dec;
16(12):e0261269.
PMID: 34928979
Adeno-associated viruses (AAV) are considered non-pathogenic in humans, and thus have been developed into powerful vector platforms for in vivo gene therapy. Although the various AAV serotypes display broad tropism,...
3.
Hamann M, Ehmele P, Verdikt R, Bialek-Waldmann J, Virdi S, Gunther T, et al.
Virus Res
. 2020 Dec;
293:198260.
PMID: 33316352
Chronic infection with human immunodeficiency virus (HIV)-1 is characterized by accumulation of proviral sequences in the genome of target cells. Integration of viral DNA in patients on long-term antiretroviral therapy...
4.
Lindel F, Dodt C, Weidner N, Noll M, Bergemann F, Behrendt R, et al.
Mol Ther Nucleic Acids
. 2019 Nov;
18:708-726.
PMID: 31726388
The adaptation of CRISPR/Cas technology for use in mammals has revolutionized genome engineering. In particular with regard to clinical application, efficient expression of Cas9 within a narrow time frame is...
5.
Camgoz A, Paszkowski-Rogacz M, Satpathy S, Wermke M, Hamann M, von Bonin M, et al.
Oncotarget
. 2018 Jun;
9(39):25458-25473.
PMID: 29876001
Acute myeloid leukemia (AML) is characterized by uncontrolled proliferation and accumulation of immature myeloblasts, which impair normal hematopoiesis. While this definition categorizes the disease into a distinctive group, the large...
6.
Zurnic I, Hutter S, Rzeha U, Helbig R, Stanke N, Reh J, et al.
PLoS Pathog
. 2016 Oct;
12(10):e1005956.
PMID: 27723818
[This corrects the article DOI: 10.1371/journal.ppat.1005860.].
7.
Hamann M, Lindemann D
Viruses
. 2016 Sep;
8(9).
PMID: 27589786
Compared with orthoretroviruses, our understanding of the molecular and cellular replication mechanism of foamy viruses (FVs), a subfamily of retroviruses, is less advanced. The FV replication cycle differs in several...
8.
Zurnic I, Hutter S, Rzeha U, Stanke N, Reh J, Mullers E, et al.
PLoS Pathog
. 2016 Sep;
12(8):e1005860.
PMID: 27579920
Unlike for other retroviruses, only a few host cell factors that aid the replication of foamy viruses (FVs) via interaction with viral structural components are known. Using a yeast-two-hybrid (Y2H)...
9.
Gebler C, Lohoff T, Paszkowski-Rogacz M, Mircetic J, Chakraborty D, Camgoz A, et al.
J Natl Cancer Inst
. 2016 Sep;
109(1).
PMID: 27576906
Although whole-genome sequencing has uncovered a large number of mutations that drive tumorigenesis, functional ratification for most mutations remains sparse. Here, we present an approach to test functional relevance of...
10.
Hamann M, Mullers E, Reh J, Stanke N, Effantin G, Weissenhorn W, et al.
Retrovirology
. 2014 Oct;
11:87.
PMID: 25292281
Background: One unique feature of the foamy virus (FV) capsid protein Gag is the absence of Cys-His motifs, which in orthoretroviruses are irreplaceable for multitude functions including viral RNA genome...